Saturday 17 October 2026
Export CVRX’s income statement to Excel — free account
CVRx, Inc.
CVRX Healthcare Medical Devices
CVRx, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $56.7 million, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 15.6%, EPS grew 7.02%, free cash flow fell 11.2% and total debt rose 18.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
1.30
0.09
−6.47%
Follow CVRX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 4 | 3 | 3 |
| (91.88%) | (96.59%) | (106.96%) | (133.44%) | ||
| (43.53%) | (44.76%) | (45.93%) | (49.06%) | ||
ROIC |
(254.15%) | (244.03%) | (204.26%) | (218.09%) | |
Return on Tangible Assets |
(52.49%) | (58.85%) | (58.89%) | (64.62%) | |
Average Days of Receivables |
53.53 | 68.71 | 56.25 | 56.08 | |
Free Cash Flow per Share |
(1.49) | (1.56) | (1.52) | (1.55) | |
Free Cash Flow |
(38.98) | (40.75) | (40.15) | (41.05) | |
Capital Expenditures |
(0.56) | (0.58) | (0.59) | (0.60) | |
| Other line items | |||||
Cash ROIC |
(21.35%) | (24.77%) | (25.11%) | (28.69%) | |
Accounts Receivable Turnover |
6.49 | 5.68 | 6.52 | 7.39 | |
Accounts Payable Turnover |
2.52 | 2.59 | 2.84 | 2.32 | |
Inventory Turnover |
0.75 | 0.68 | 0.68 | 0.65 | |
Average Days of Payables |
152.51 | 168.34 | 134.05 | 176.64 | |
Days of Inventory on Hand |
478.96 | 536.02 | 554.59 | 594.03 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
19.54% | 19.65% | 19.80% | 20.20% | |
Selling, General and Administrative Expense of Revenue |
154.91% | 156.17% | 151.00% | 146.20% | |
Share Based Compensation of Revenue |
19.55% | 19.51% | 19.49% | 20.04% | |
Interest Coverage |
(8.49) | (8.80) | (8.44) | (8.07) | |
Operating CF/Net income |
0.74 | 0.75 | 0.75 | 0.78 | |
Depreciation/Fixed assets |
0.40 | 0.44 | 0.48 | 0.53 | |
Capex/Depreciation |
(0.57) | (0.58) | (0.56) | (0.55) | |
Revenue per Share |
2.14 | 2.17 | 2.24 | 2.31 | |
Operating CF per Share |
(1.47) | (1.54) | (1.50) | (1.53) | |
Capex per Share |
(0.02) | (0.02) | (0.02) | (0.02) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates